Expand Exports to Double Operating Profit
This news is translated from The Chemical Daily.
Dawnrays’ New factory in Suzhou is expected to be completed in 2011 ---and import the latest equipment of Europe.
Recently the President of Dawnrays Pharmaceutical—Mr. Gao yi gives an interview. The company is based on cephalosporin in the Chinese market, and determined the plan of expanding exports to increase profit.
Dawnrays has a number of generic drug exports to the Middle East and Africa, but seldom exports to the United States, Europe, and Japan. So Dawnrays decided to set up the new factory in 2011, import the advanced production equipment of Europe, reaching the quality of Europe and the United States standards, and hope to expand exports.
Dawnrays' 2007 operating profit is 17% over the previous year, reaching 920 million (about ¥ 13,800,000,000). The company achieves sustained growth operating profit year by year, and doubled profit compared with the 2003. President Mr. Gao said, Dawnrays considered cephalosporins and a variety of generic drugs as the pillar industry. And we have the capacity of 800 tons cephalosporin every year. In the Chinese market, cephalosporins have a high market share.
In order to expand exports, Dawnrays is expected to complete the new factory in 3 years, which is located at WuZhong Economic Development Zone. And import the advanced equipment of Europe. Dawnrays expected half operating profit of future production of tablet and capsule in new factory will come from exports.
